Skip to content
1 min left · finish 2:17 AM
Email
Bangkok
Bangkok
Meridan ReportBangkok: Southeast Asia's tech and finance hub
Good evening, Columbus⛅63°F · Cloudy
TechnologyBusinessCommunitySchoolsGovernment
+5 more
SportsReal EstateDiningArtsHealth

Advertisement · Why this ad?

  1. Home
  2. /Health
  3. /Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner
Health

Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner

Katherine Langford
Katherine Langford
Katherine Langford
Editor-in-Chief · Edina, MN

Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.

More from Katherine →
Editor-in-Chief · Monday, November 2, 2026 at 12:30 AM · 1 min read
Text size
Typeface
Line spacing
Theme
Focus mode
Email
Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner — Bangkok Health news

Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong, making it the first company from the country to partner with the city’s government under a flagship investment initiative. Rohto, known for its over-the-counter eye care and skincare products, is among the latest batch of 18 firms recruited by the Office for Attracting Strategic Enterprises (OASES), a...

Up nextHow could a single gene-editing injection treat inherited eye diseases?Health · 1 min read

More Health stories

How could a single gene-editing injection treat inherited eye diseases? — South China Morning Post
Health

How could a single gene-editing injection treat inherited eye diseases?

By Marcus Chen

Ex-Japanese adult film actress in intensive care after alleged drugging in Hong Kong — South China Morning Post
Health

Ex-Japanese adult film actress in intensive care after alleged drugging in Hong Kong

By Katherine Langford

‘Be alive’: Hongkonger with muscular dystrophy turns 18, against all odds — South China Morning Post
Health

‘Be alive’: Hongkonger with muscular dystrophy turns 18, against all odds

By Katherine Langford

Hongkongers need more than 4 walls and a roof to make a home — South China Morning Post
Health

Hongkongers need more than 4 walls and a roof to make a home

By Katherine Langford

Also covering Global

DublinSão PauloMexico CityAtlantaDenver

Meridan Report — Bangkok

Part of the Meridan Report Network

Bangkok: Southeast Asia's tech and finance hub. Finance, AI, and technology intelligence across 40 global cities.

Sections

TechnologyBusinessCommunitySchoolsGovernmentSports

Latest Stories

Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partnerSingapore haze: 24-hr PSI readings in the good-to-moderate across the countryHumans vs AI art: why game studios hire Southeast Asian talentMichael Mann, director of Heat and Collateral, accidentally shoots self at gun rangeChemotherapy left her feet too swollen for shoes but this single mum kept running: 'It saved my life'

About

Meridan Report delivers institutional-grade intelligence on finance, AI, and technology from 40 global markets.

RSS FeedNetwork Directory

© 2026 Meridan Report — meridanreport.com

PrivacyTerms

A product of Edina Automation LLC

You're offline — showing the last loaded page
HomeSearchSaved